F-group (family)
2003.1.5.56 CoV_Methyltr_2
Ligands and drugs
99
Member domains
98
with ligand contacts (≤ 4 Å)
99.0% of members
62
with DrugDomain annotations
62.6% of members
62
with a DrugBank compound
62.6% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2003.1.5.56 belongs to X-group 2003 Rossmann-like, which binds 8.9 ligand superclasses per 20 proteins, broader than 78% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00118 | SAM | Ademetionine | 21 |
| DB01752 | SAH | S-adenosyl-L-homocysteine | 17 |
| DB01649 | GTA | 7-methyl-GpppA | 12 |
| DB01910 | SFG | Sinefungin | 8 |
| DB02716 | MGP | 7-methyl-guanosine-5'-triphosphate | 4 |
| DB03958 | GTG | 7-methyl-guanosine-5'-triphosphate-5'-guanosine | 4 |
| DB02561 | BDF | Beta-D-Fructopyranose | 3 |
| DB00640 | ADN | Adenosine | 2 |
| DB01960 | M7G | 7-methyl-7,8-dihydroguanosine-5'-diphosphate | 2 |
| DB02282 | MTA | 5'-S-methyl-5'-thioadenosine | 2 |
| DB00131 | AMP | Adenosine phosphate | 1 |
| DB00145 | GLY | Glycine | 1 |
| DB00171 | ATP | ATP | 1 |
| DB00173 | ADE | Adenine | 1 |
| DB03172 | TBN | Tubercidin | 1 |
| DB04604 | 5ID | 5-iodotubercidin | 1 |
| DB13916 | TO1 | Toyocamycin | 1 |
| DB16833 | ADP | Adenosine disphosphate | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| SAM | S-ADENOSYLMETHIONINE | 36 |
| CL | CHLORIDE ION | 26 |
| SAH | S-ADENOSYL-L-HOMOCYSTEINE | 23 |
| NAmetal | SODIUM ION | 22 |
| GTA | P1-7-METHYLGUANOSINE-P3-ADENOSINE-5',5'-TRIPHOSPHATE | 17 |
| MGmetal | MAGNESIUM ION | 10 |
| SFG | SINEFUNGIN | 8 |
| MGP | 7-METHYL-GUANOSINE-5'-TRIPHOSPHATE | 6 |
| GTG | 7-METHYL-GUANOSINE-5'-TRIPHOSPHATE-5'-GUANOSINE | 4 |
| V9G | 7-METHYL-GUANOSINE-5'-TRIPHOSPHATE-5'-(2'-O-METHYL)-ADENOSINE | 4 |
| BDF | beta-D-fructopyranose | 3 |
| MTA | 5'-DEOXY-5'-METHYLTHIOADENOSINE | 3 |
| SGV | SANGIVAMYCIN | 3 |
| TO1 | 4-amino-7-(beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile | 3 |
| A1IOL | ~{N}-[(5~{S})-5-azanyl-6-[(3~{S},4~{S},6~{R})-3-[1,3-dimethyl-2,6-bis(oxidanylidene)purin-7-yl]-4-methyl-4,6-bis(oxidanyl)azepan-1-yl]-6-oxidanylidene-hexyl]ethanamide | 2 |
| ADN | ADENOSINE | 2 |
| GLC | alpha-D-glucopyranose | 2 |
| M7G | 7N-METHYL-8-HYDROGUANOSINE-5'-DIPHOSPHATE | 2 |
| XDU | 4-[(E)-2-(2,4-dichlorophenyl)ethenyl]-6-(trifluoromethyl)pyrimidin-2-ol | 2 |
| 4IK | (2S,5S)-2,6-diamino-5-{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl}hexanoic acid | 1 |